Abstract:Objective To study the clinical significance on the combined determination of serum N-terminal pro-B-type natriuretic peptide (NT-proBNP),heart-type fatty acid-binding protein(H-FABP)and cardiac troponin I(cTnI)in elder patients with severe heart failure (HF ).Methods The serum NT-proBNP,H-FABP and cTnI levels were determined in 31 2 elder patients with severe HF {main adverse cardiovascular event (MACE )group (1 94 cases ) [cardiogenic readmission group(1 1 0 cases)and death group(84 cases)]and no-MACE group(1 1 8 cases)}on admission, day 7,1 5,30 and 60 after treatment,76 elder patients with no-severe HF and 40 elder healthy subjects.The MACE were followed and observed for 1 80 d.The significance of NT-proBNP,H-FABP and cTnI for the diagnosis of severe HF and the prediction of death risk was analyzed by receiver operating characteristic(ROC)curve.Survival analysis was performed by Kaplan-Meier curve.Results The serum NT-proBNP,H-FABP and cTnI levels in elder patients with severe HF were significantly higher than those in elder patients with no-severe HF and healthy subjects (P<0.01 ),the positive rate of H-FABP in elder patients with no-severe HF was 47.1%,and the positive rate of cTnI was 4.5%.The serum NT-proBNP levels were positively correlated with the grade of New York Heart Association (NYHA)Ⅰ-Ⅳ(r=0.77,P<0.01 ).The ROC curve indicated that the optimal cut-off values of serum NT-proBNP,H-FABP and cTnI levels for diagnosis in elder patients with severe HF were 4 601 .50 ng/L,5.1 6 ng/L and 0.025 ng/mL,and the optimal cut-off values of serum NT-proBNP,H-FABP and cTnI levels for the death risk evaluation in elder patients with severe HF were 8 1 78.50 ng/L, 1 1 .77ng/L and 0.038ng/mL,respectively.The sensitivity of the combined determination was obviously better than those of the individual determinations (P<0.05 ).Before the treatment,the serum NT-proBNP levels in MACE group were significantly higher than those in no-MACE group(P<0.05),the serum H-FABP levels in death group were significantly higher than those in no-death group(P<0.05 ),and the serum cTnI levels in various prognosis groups had no statistical significance (P>0.05 ).The serum NT-proBNP,H-FABP and cTnI levels in no-MACE group on day 7 after treatment were significantly lower than those before the treatment (P<0.05 ).The decreasing rates of the 3 parameters were >50%,and the serum H-FABP level was lower than the normal reference value.The serum NT-proBNP,H-FABP and cTnI levels in the cardiogenic readmission group on day 1 5 after treatment were significantly lower than those before treatment (P<0.05),but the decreasing rates of the 3 parameters were <30%,and the serum H-FABP level was higher than the normal reference value.The serum NT-proBNP,H-FABP and cTnI levels in death group on day 7 and day 30 after treatment were significantly higher than those before treatment(P<0.05),and the serum cTnI levels were higher than the normal reference value.Kaplan-Meier survival curve showed that the survival rates of serum NT-proBNP,H-FABP and cTnI levels had significant difference (P <0.05 ).Conclusions There is an important clinical significance of the combined determination of serum NT-proBNP,H-FABP and cTnI levels for the diagnosis,prognosis,death risk evaluation and curative effect survey in elder patients with severe HF.

Study on the relationship between the serum Copeptin level and the syndrome differentiation of traditional Chinese medicine in patients with chronic heart failure

A Correlative Study on Insidious Pathogen of Phlegm and Blood Stasis with Cardiac Functional Grading, NT-proBNP and Echocardiography of Patients with CHD-Related Heart Failure

Levels and clinical significance of serum NT-proBNP, UA and hs-CRP in chronic heart failure

[A Correlation Research on Chinese Medical Syndromes of Chronic Heart Failure and Various Complications].

Correlation Between ACE2 ,ACE2 Antibody ,Ang-(1-7 ) and NT-proBNP in Patients with Chronic Heart Failure

Identification and Comparison of Potential Biomarkers by Proteomic Analysis in Traditional Chinese Medicine-Based Heart Failure Syndromes

Study on the Differences between Traditional Chinese Medicine Syndromes in NYHA I–IV Classification of Chronic Heart Failure

Clinical Study of Relationships Between FIB HS-CRP Respectively in CHD with Various TCM Syndromes

Study on the Correlation of Serum Lipoprotein (a),pro-BNP,Troponin I and Total Bilirubin with the Prognosis of Patients with Chronic Heart Failure

Clinical value of serum copeptin on risk stratification and prognosis in patients with acute coronary syndrome

Relation between three biomarkers and prognosis of heart failure

The Clinical Significance on the Combined Determination of NT-proBNP,H-FABP and Ctni in Elder Patients with Severe Heart Failure

Clinical Study of Relationships between Fibrinogen Respectively in CHD with Various TCM Syndromes

Mechanism of Chinese Medicine Herbs Effects on Chronic Heart Failure Based on Metabolic Profiling

Validation of evidence-based questionnaire for TCM syndrome differentiation of heart failure and evaluation of expert consensus

The value of diagnosis and prognosis diagnostic on heart failure patients by joint detection with CTnI, hs-CRP and NT-ProBNP

Correlation of CHD Clinical Index with Traditional Chinese Medicine's Differentiation of Symptoms and Signs for Classification of Syndrome

Comparative study of serum BNP between chronic pulmonary heart disease and left heart failure

Relationships between Plasma Fibrinogen in Coronary Heart Disease with Various TCM Syndromes

Relationship Between Serum cTnI/cTnT in Patients with Chronic Heart Failure and Different Cardiovascular Diseases

Correlative Study Between Plasma NO and Various TCM Syndromes in CHD